The U.S. Meals and Drug Administration (FDA) has cleared an investigational new drug utility from Scancell Holdings plc for a registrational section 3 trial of...
The U.S. Meals and Drug Administration (FDA) has accepted a supplemental biologics license utility and granted precedence evaluation for Datroway (datopotamab deruxtecan) for the therapy...
Final week, the U.S. Meals and Drug Administration (FDA) accredited the usage of Darzalex Faspro (daratumumab and hyaluronidase-fihj) together with Velcade (bortezomib), Revlimid (lenalidomide) and...
